STAT+: Pharmalittle: J&J Covid-19 vaccine supply will be uneven; pandemic ushers in a ‘golden age of vaccinology’

Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended, in our case — was somehow relaxing and invigorating, since the usual weekday routine has predictably returned. After all, the world keeps spinning. With this in mind, why not have a cup of stimulation and give it a push? Our choice today is vanilla caramel cream. Please feel free to join us. Meanwhile, here are a few items of interest to help you get going. We hope your day is productive and peaceful. …

Health care providers will begin receiving the first 3.9 million doses of the newly authorized Johnson & Johnson (JNJ) Covid-19 vaccine as early as Tuesday morning, though supply will be uneven in the coming weeks, STAT explains, citing senior Biden administration officials. The first shipments account for the entirety of J&J’s current inventory. Officials expect another 16 million doses to be available by the end of March, though J&J told the federal government that the doses will be delivered mostly toward the second half of the month.

Continue to STAT+ to read the full story…

STAT+: Pharmalittle: J&J Covid-19 vaccine supply will be uneven; pandemic ushers in a ‘golden age of vaccinology’

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top